Sloan-Kettering Shines a Light on Nanotech Imaging
This article was originally published in Start Up
Executive Summary
Researchers at Memorial Sloan-Kettering and Cornell University have taken the first steps toward moving a silica-based nanoparticle platform invented at Cornell into use in cancer imaging. Using optical imaging and PET, they showed that encapsulating a dye in a biocompatible nanoscale matrix enhanced imaging capabilities while maintaining efficient clearance through the urine.